Abstract:The aim of the present study was to compare the bioavailability of escitalopram (CAS 128196-01-0) from two escitalopram oxalate (CAS 219861-08-2) tablets (escitalopram 10 mg tablet as test preparation and 10 mg tablet commercially available original tablet of the drug as reference preparation) in 20 Chinese healthy male volunteers, aged between 19 and 27. The study was conducted according to an open, randomized, single blind, 2-way crossover study design with a wash-out phase of 14 d. Blood samples for pharmacokinetic profiling were taken up to 156 h post-dose, and escitalopram plasma concentrations were determined with a validated liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) method. Maximum plasma concentrations (C(max)) of 9.85 +/- 1.79 ng/ml (test) and 9.92 +/- 2.14 ng/ml (reference) were achieved. Areas under the plasma concentration-time curve (AUC(0-infinity)) of 428.40 +/- 140.25 ng x h/ml (test) and 413.73 +/- 144.81 ng x h/ml (reference), AUC(0-t) of 401.33 +/- 120.61 ng x h/ml (test), 385.42 +/- 117.73 ng x h/ml (reference) were calculated. The median T(max) was 4.3 +/- 1.8h, 4.1 +/- 1.5 h for test and reference formulation, respectively. Plasma elimination half-lives (t 1/2) of 36.30 +/- 8.93 h (test), 36.70 +/- 9.99 h (reference) were determined. Both primary target parameters, AUC(0-infinity) and AUC(0-t) were tested parametrically by analysis of variance (ANOVA) and relative bioavailabilities were 105.1 +/- 10.8% for AUC(0-infinity), 104.9 +/- 11.1% for AUC(0-t). Bioequivalence between test and reference preparation was demonstrated for both parameters, AUC(0-infinity) and AUC(0-t). The 90% confidence intervals of the T/R-ratios of logarithmically transformed data were in the generally accepted range of 80%-125%. That means that the test formulation is bioequivalent to the reference formulation for escitalopram.

Pharmacokinetics and bioequivalence of sertraline capsules and tablets

Bioequivalence of oral sertraline hydrochloride tablets and dispersible tabletsin healthy volunteers

Determination of Sertraline in Human Plasma by LC-MS: Application to Relative Bioavailability of Domestic and Imported Sertraline Tablets

Study on pharmacokinetic of sertraline in chinese healthy volunteers

Bioequivalence Study of Paroxetine Hydrochloride Film-Coated Tablets

Bioequivalence study of fluoxetine capsules in healthy volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Pharmacokinetics and bioequivalence study of escitalopram oxalate formulations after single-dose administration in healthy Chinese male volunteers

Study on bioequivalence of trimetazidine capsule and tablet in healthy volunteers

Pharmacokinetic and Bioequivalence Study of Tropisetron Chlorate Capsule in Human

Pharmacokinetics and Bioequivalance of Clarithromycin Dispersed Tablet in Healthy Volunteers

Bioequivalence of cefprozil tablets in healthy volunteers

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Bioequivalence of zopiclone tablet in Chinese healthy volunteers

Study on Bioequivalence of Risperidone Tablets

Pharmacokinetics and Bioequivalence of Two Metoprolol Succinate Extended Release Tablets in Healthy Chinese Subjects under Fasting and Fed Conditions.

Bioeguivalent Study of Two Fluconazole Capsules in Human Plasma

Bioequivalent Study of Citalopram Tablets

Development and validation of an improved method for the quantitation of sertraline in human plasma using LC-MS-MS and its application to bioequivalence studies.

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers

Pharmacokinetics and Bioequivalence of Venlafaxine Hydrochloride Capsules in Healthy Volunteers